NasdaqCM - Nasdaq Real Time Price USD

IM Cannabis Corp. (IMCC)

Compare
2.6999 -0.1301 (-4.75%)
As of 1:20 PM EST. Market Open.
Loading Chart for IMCC
DELL
  • Previous Close 2.8300
  • Open 2.7700
  • Bid --
  • Ask --
  • Day's Range 2.6000 - 2.9000
  • 52 Week Range 1.1340 - 8.1000
  • Volume 7,058
  • Avg. Volume 17,160
  • Market Cap (intraday) 8.33M
  • Beta (5Y Monthly) 1.68
  • PE Ratio (TTM) --
  • EPS (TTM) -4.1400
  • Earnings Date Nov 14, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers medical cannabis dried flowers; and full-spectrum, strain-specific cannabis extracts under the IMC, BLKMT, WAGNERS, and LOT420 brands. The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Tel Aviv, Israel.

imcannabis.com

95

Full Time Employees

December 31

Fiscal Year Ends

Recent News: IMCC

View More

Performance Overview: IMCC

Trailing total returns as of 11/22/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

IMCC
26.05%
S&P/TSX Composite index
21.37%

1-Year Return

IMCC
7.14%
S&P/TSX Composite index
26.49%

3-Year Return

IMCC
98.53%
S&P/TSX Composite index
18.01%

5-Year Return

IMCC
90.89%
S&P/TSX Composite index
69.61%

Compare To: IMCC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: IMCC

View More

Valuation Measures

Annual
As of 11/21/2024
  • Market Cap

    8.26M

  • Enterprise Value

    18.06M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.17

  • Price/Book (mrq)

    2.03

  • Enterprise Value/Revenue

    0.49

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -28.25%

  • Return on Assets (ttm)

    -17.18%

  • Return on Equity (ttm)

    -112.01%

  • Revenue (ttm)

    49.88M

  • Net Income Avi to Common (ttm)

    -14.09M

  • Diluted EPS (ttm)

    -4.1400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    700k

  • Total Debt/Equity (mrq)

    287.21%

  • Levered Free Cash Flow (ttm)

    -188.12k

Research Analysis: IMCC

View More

Company Insights: IMCC

Research Reports: IMCC

View More

People Also Watch